572 related articles for article (PubMed ID: 28528353)
1. Adrenomedullin ameliorates podocyte injury induced by puromycin aminonucleoside in vitro and in vivo through modulation of Rho GTPases.
Dong N; Meng L; Xue R; Yu M; Zhao Z; Liu X
Int Urol Nephrol; 2017 Aug; 49(8):1489-1506. PubMed ID: 28528353
[TBL] [Abstract][Full Text] [Related]
2. Cyclic AMP prevents decrease of phosphorylated ezrin/radixin/moesin and chloride intracellular channel 5 expressions in injured podocytes.
Tao H; Li X; Wei K; Xie K; Ni Z; Gu L
Clin Exp Nephrol; 2015 Dec; 19(6):1000-6. PubMed ID: 25725994
[TBL] [Abstract][Full Text] [Related]
3. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling.
Shibata S; Nagase M; Fujita T
J Am Soc Nephrol; 2006 Mar; 17(3):754-64. PubMed ID: 16452496
[TBL] [Abstract][Full Text] [Related]
4. Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.
Okada T; Sakaguchi T; Hatamura I; Saji F; Negi S; Otani H; Muragaki Y; Kawachi H; Shigematsu T
Clin Exp Nephrol; 2009 Oct; 13(5):438-446. PubMed ID: 19452240
[TBL] [Abstract][Full Text] [Related]
5. Podocin is translocated to cytoplasm in puromycin aminonucleoside nephrosis rats and in poor-prognosis patients with IgA nephropathy.
Fukuda H; Hidaka T; Takagi-Akiba M; Ichimura K; Oliva Trejo JA; Sasaki Y; Wang J; Sakai T; Asanuma K; Tomino Y
Cell Tissue Res; 2015 May; 360(2):391-400. PubMed ID: 25676004
[TBL] [Abstract][Full Text] [Related]
6. GIV/girdin links vascular endothelial growth factor signaling to Akt survival signaling in podocytes independent of nephrin.
Wang H; Misaki T; Taupin V; Eguchi A; Ghosh P; Farquhar MG
J Am Soc Nephrol; 2015 Feb; 26(2):314-27. PubMed ID: 25012178
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of absolute amount of nephrin in a single podocyte in puromycin aminonucleoside nephrosis rats calculated by quantitative glomerular proteomics approach with selected reaction monitoring mode.
Kawakami H; Kamiie J; Yasuno K; Kobayashi R; Aihara N; Shirota K
Nephrol Dial Transplant; 2012 Apr; 27(4):1324-30. PubMed ID: 21862459
[TBL] [Abstract][Full Text] [Related]
8. Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro.
Zheng CX; Chen ZH; Zeng CH; Qin WS; Li LS; Liu ZH
Kidney Int; 2008 Sep; 74(5):596-612. PubMed ID: 18509322
[TBL] [Abstract][Full Text] [Related]
9. Rho-family small GTPases are involved in forskolin-induced cell-cell contact formation of renal glomerular podocytes in vitro.
Gao SY; Li CY; Shimokawa T; Terashita T; Matsuda S; Yaoita E; Kobayashi N
Cell Tissue Res; 2007 May; 328(2):391-400. PubMed ID: 17265067
[TBL] [Abstract][Full Text] [Related]
10. Expression and regulation of adrenomedullin in renal glomerular podocytes.
Hino M; Nagase M; Kaname S; Shibata S; Nagase T; Oba S; Funaki M; Kobayashi N; Kawachi H; Mundel P; Fujita T
Biochem Biophys Res Commun; 2005 Apr; 330(1):178-85. PubMed ID: 15781248
[TBL] [Abstract][Full Text] [Related]
11. Syndecan-4 ectodomain evokes mobilization of podocyte TRPC6 channels and their associated pathways: An essential role for integrin signaling.
Kim EY; Roshanravan H; Dryer SE
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2610-20. PubMed ID: 26193076
[TBL] [Abstract][Full Text] [Related]
12. The immunosuppressive drug mizoribine directly prevents podocyte injury in puromycin aminonucleoside nephrosis.
Takeuchi S; Hiromura K; Tomioka M; Takahashi S; Sakairi T; Maeshima A; Kaneko Y; Kuroiwa T; Nojima Y
Nephron Exp Nephrol; 2010; 116(1):e3-10. PubMed ID: 20502051
[TBL] [Abstract][Full Text] [Related]
13. Adrenomedullin protects against oxidative stress-induced podocyte injury as an endogenous antioxidant.
Oba S; Hino M; Fujita T
Nephrol Dial Transplant; 2008 Feb; 23(2):510-7. PubMed ID: 17981883
[TBL] [Abstract][Full Text] [Related]
14. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
Kim BS; Park HC; Kang SW; Choi KH; Ha SK; Han DS; Lee HY
Yonsei Med J; 2005 Feb; 46(1):141-8. PubMed ID: 15744817
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of the Rho kinase inhibitor Y27632 in murine puromycin aminonucleoside nephrosis.
Wang L; Ellis MJ; Fields TA; Howell DN; Spurney RF
Kidney Blood Press Res; 2008; 31(2):111-21. PubMed ID: 18367845
[TBL] [Abstract][Full Text] [Related]
16. Semi-automated quantitative image analysis of podocyte desmin immunoreactivity as a sensitive marker for acute glomerular damage in the rat puromycin aminonucleoside nephrosis (PAN) model.
Herrmann A; Tozzo E; Funk J
Exp Toxicol Pathol; 2012 Jan; 64(1-2):45-9. PubMed ID: 20591637
[TBL] [Abstract][Full Text] [Related]
17. Key molecular events in puromycin aminonucleoside nephrosis rats.
Guan N; Ding J; Deng J; Zhang J; Yang J
Pathol Int; 2004 Sep; 54(9):703-11. PubMed ID: 15363039
[TBL] [Abstract][Full Text] [Related]
18. Renoprotective effect of topiroxostat via antioxidant activity in puromycin aminonucleoside nephrosis rats.
Kawamorita Y; Shiraishi T; Tamura Y; Kumagai T; Shibata S; Fujigaki Y; Hosoyamada M; Nakagawa T; Uchida S
Physiol Rep; 2017 Aug; 5(15):. PubMed ID: 28774949
[TBL] [Abstract][Full Text] [Related]
19. Induction of podocyte-derived VEGF ameliorates podocyte injury and subsequent abnormal glomerular development caused by puromycin aminonucleoside.
Ma J; Matsusaka T; Yang HC; Zhong J; Takagi N; Fogo AB; Kon V; Ichikawa I
Pediatr Res; 2011 Jul; 70(1):83-9. PubMed ID: 21451433
[TBL] [Abstract][Full Text] [Related]
20. Nephrin phosphorylation regulates podocyte adhesion through the PINCH-1-ILK-α-parvin complex.
Zha D; Chen C; Liang W; Chen X; Ma T; Yang H; Goor Hv; Ding G
BMB Rep; 2013 Apr; 46(4):230-5. PubMed ID: 23615266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
